Human Mesenchymal Stem Cells Reprogram Adult Cardiomyocytes Toward a Progenitor-Like State Through Partial Cell Fusion and Mitochondria Transfer§

Authors


  • Author contributions: A.A., T.B., and A.M.R.: conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing; P.F.L., F.F., A.E.C., and O.L.C.: collection and assembly of data, data analysis and interpretation; C.C. and X.B.: collection and assembly of data; F.A.: provision of study material or patients; R.Y.: conception and design, final approval of manuscript; J.L.D.: financial support, conception and design, final approval of manuscript. A.A. and T.B. contributed equally to this article.

  • First published online in STEM CELLS EXPRESS March 23, 2011.

  • §

    Disclosure of potential conflicts of interest is found at the end of this article.

Abstract

Because stem cells are often found to improve repair tissue including heart without evidence of engraftment or differentiation, mechanisms underlying wound healing are still elusive. Several studies have reported that stem cells can fuse with cardiomyocytes either by permanent or partial cell fusion processes. However, the respective physiological impact of these two processes remains unknown in part because of the lack of knowledge of the resulting hybrid cells. To further characterize cell fusion, we cocultured mouse fully differentiated cardiomyocytes with human multipotent adipose-derived stem (hMADS) cells as a model of adult stem cells. We found that heterologous cell fusion promoted cardiomyocyte reprogramming back to a progenitor-like state. The resulting hybrid cells expressed early cardiac commitment and proliferation markers such as GATA-4, myocyte enhancer factor 2C, Nkx2.5, and Ki67 and exhibited a mouse genotype. Interestingly, human bone marrow-derived stem cells shared similar reprogramming properties than hMADS cells but not human fibroblasts, which suggests that these features might be common to multipotent cells. Furthermore, cardiac hybrid cells were preferentially generated by partial rather than permanent cell fusion and that intercellular structures composed of f-actin and microtubule filaments were involved in the process. Finally, we showed that stem cell mitochondria were transferred into cardiomyocytes, persisted in hybrids and were required for somatic cell reprogramming. In conclusion, by providing new insights into previously reported cell fusion processes, our data might contribute to a better understanding of stem cell-mediated regenerative mechanisms and thus, the development of more efficient stem cell-based heart therapies. STEM CELLS 2011;29:812–824

INTRODUCTION

Heart degenerative diseases such as myocardial infarction and heart failure are among the main causes of death in western countries. Such mortality has its roots in the poor ability of the myocardium to restore cardiomyocyte loss upon injury, which explains why rebuilding the damaged heart remains a critical challenge. One of the most promising approaches to repair this organ is cell therapy, particularly which is based on multipotent adult stem cells [1–3] because such cells might benefit from immune privilege [3, 4] and can be expanded on a large scale in vitro [1–3]. However, although many studies suggested the benefit of stem cell grafting, the mechanisms by which such cells contribute to cardiac wound healing remain a matter of debate.

The functional benefit of stem cells may result from several processes, including transdifferentiation into cardiac and endothelial cells [5–7] or secretion of paracrine factors with various effects such as protection against apoptosis and induction of angiogenesis [8]. Another intriguing possibility is that permanent cell fusion between stem cells and resident cardiac cells may promote replacement of the dead myocardium by generating new cardiomyocytes in response to injury. Indeed, several in vivo and in vitro studies involving the Cre/loxP system or transgenic rodents expressing green fluorescent protein (GFP) or β-galactosidase reporter genes showed that both adult and embryonic stem cells could fuse with somatic cells such as neurons, hepatocytes, and cardiomyocytes [9–11]. Permanent cell fusion results in the formation of binucleated heterokaryons, which in some cases undergo nuclear fusion to give rise to mononucleated hyperploid synkaryons. In heart tissue, permanent cell fusion has been detected after stem cell delivery in various settings, including the healthy neonatal heart [12], myocardial infarction [13–15], mdx dystrophin-deficient cardiomyopathy [16], and monocrotaline-induced hypertension [17]. However, despite evidence of hybrid cells with a cardiac phenotype [13–17], such a phenomenon was described as being extremely rare and led critics to cast doubts on its biological significance [6, 18, 19].

Recently, two in vitro studies mimicking the cardiac environment by coculturing stem cells and cardiomyocytes suggested that hybrid cells may be generated by a mechanism other than permanent cell fusion, one that consists of partial cell fusion through transient direct cell-to-cell communication and intercellular exchange of various compounds [20, 21]. This new transient cell fusion pathway, discovered in 2004, is based on the formation of membrane thin channels, referred to as tunneling nanotubes, that mediate membrane continuity between connected cells, sometimes over long distances [22]. These nanotubular structures have been found to connect a broad range of cultured mammalian cells [23] and to permit transfer of several components such as multiprotein complexes [24], organelles [25–27], and pathogens [28–30]. Specially, stem cells and cardiomyocytes have been reported to exchange in vitro cytoplasm macromolecules and organelles through intercellular structures resembling nanotubes [20, 21]. However, whether these cellular transfers play a role in cell fate change and tissue repair remains to be formally demonstrated.

Thus, the phenomenon of cell fusion in heart tissue appears to be poorly understood. In particular, the respective physiological importance of partial versus permanent cell fusion processes is unclear, and little is known about the cellular and molecular mechanisms underlying spontaneous generation of hybrid cells as well as the characterization of their phenotypes.

Here, we hypothesized that stem cell-mediated fusion with terminally differentiated cells constitutes a regenerative mechanism by which the nuclei of somatic cells are reprogrammed, thus resulting in selective survival and proliferative advantages. To promote cell fusion events, we developed a species mismatch coculture approach using mouse terminally differentiated cardiomyocytes and human multipotent adipose-derived stem (hMADS) cells [3] as a model of adult stem cells. Using a Cre/loxP system, we found that hMADS cells could reprogram postmitotic murine cardiomyocytes into proliferating cardiac progenitor-like cells through spontaneous cell fusion. In addition, we showed that successful somatic reprogramming of cardiomyocytes required both intercellular structures composed of f-actin and microtubules and transfer of functional stem cell mitochondria into cardiomyocytes.

MATERIALS AND METHODS

Cell Isolation and Culture

For hMADS cell isolation, adipose tissues were obtained from young donors, with written informed consent of the parents, as surgical scraps from surgical specimens obtained from various surgeries, as approved by the Regional Ethical Committee (“Comité de Protection des Personnes Ile de France IX”). hMADS cells were isolated as described previously [3]. Human bone marrow mesenchymal stem (hBMS) cells were a generous gift from Dr. Hélène Rouard (Etablissement Français du Sang, Créteil, France). hBMS cells were isolated from iliac-crest bone marrow aspirates from patients undergoing standard bone marrow transplantation (Henri Mondor Hospital, Créteil, France) after receiving their informed consent [31].

The human lung fibroblast MRC5 cell line was a gift from Dr. Jorge Boczkowski (INSERM U955, Créteil). hMADS cells, hBMS cells, and MRC5 cells were cultured in Dulbecco's modified Eagle's medium (DMEM), 1 g/l glucose containing 10% heat inactivated fetal bovine serum (FBS) (Dominique Dutscher, Brumath, France, www.dutscher.com), 100 U/ml penicillin, 100 μg/ml streptomycin, and 10 mM HEPES (Invitrogen, Cergy Pontoise, France, www.invitrogen.com) in a 5% CO2 atmosphere at 37°C. As described [3], hMADS cells had the following phenotype: CD44+, CD49b+, CD105+, CD90+, CD13+, Stro-1, CD34, CD15, CD117, Flk-1, Gly-A, CD133, HLA-DR, and HLA-Ilow.

Generation of hMADS Cells Devoid of Functional Mitochondria (hMADSρ0 Cells)

For mitochondrial DNA depletion, hMADS cells were cultivated in DMEM supplemented with 10% FBS and 0.5 μg/ml ethidium bromide (Sigma-Aldrich, Saint-Quentin Fallavier, France, www.sigmaaldrich.com), 50 μg/ml uridine, and 100 μg/ml pyruvate for at least 1-month [32–34].

Isolation of Adult Mouse Ventricular Myocytes

Ventricular cardiomyocytes were isolated from hearts of 2–5 months old male mice after intracardiac perfusion of enzymatic solution containing 12.5 μM CaCl2 (Sigma-Aldrich), 0.1 mg/ml liberase blendzyme IV (Roche Diagnostics, Meylan, France, www.rochediagnostics.fr), 0.14 mg/mL trypsine (Sigma-Aldrich), as described [35]. Cardiomyocytes were obtained from several mouse lines, including C57BL/6J mice (Janvier, Le Genest Saint Isle, France, www.janvier-europe.com), GCAG-GFP transgenic mice [36] (gift of Dr. Fabrice Chrétien, Pasteur Institute, Paris, France) and Rosa26R transgenic mice (gift of Dr. Shaharagim Tajbakhsh, Pasteur Institute).

Coculture with Adult Mouse Cardiomyocytes

Freshly isolated mouse cardiomyocytes were cocultured with hMADS cells, hBMS cells, or MRC5 cells in DMEM supplemented with 10% FBS in a 1:1 ratio, each cell type seeded at 3,500 cells per square centimeter. In experiments preventing physical contact between the two cell types, cardiomyocytes were seeded on cell-culture inserts containing a polycarbonate membrane with a 0.4-μm pore (Millicell, Millipore) placed in 35 mm dishes plated with hMADS cells.

To assess passive human mitochondria transfer, cells were indirectly cocultured by use of polycarbonate cell-culture inserts with an 8-μm pore (Millicell, Millipore, Molsheim, France, www.millipore.com). For coculture with hMADSρ0 cells, culture medium was supplemented with 50 μg/ml uridine and 100 μg/ml pyruvate to permit survival of stem cells devoid of functional mitochondria.

Detection of Cell Fusion

For detection of fused cells, hMADS cells were infected with a human serotype V adenovirus-expressing Cre under a cytomegalovirus promoter (gift of Dr. Athanassia Sotiropoulos, Cochin Institute, Paris, France) at a multiplicity of infection of 50 at 72 hours before coculture with Rosa26R cardiomyocytes. Rosa26R mice carried the lacZ gene that encodes for β-galactosidase under the control of an internal stop codon flanked by loxP sites [37]. When Cre-expressing cells fuse with Rosa26R cells, Cre recombinase contacts the genome of Rosa26R cells and excises its floxed stop cassette, thus resulting in expression of LacZ in the fused cells. Consequently, fused cells and their progeny can be detected by Xgal staining (substrate of β-galactosidase) or by immunocytochemistry with antibodies against β-galactosidase.

Xgal Staining

For Xgal staining, cocultured cells were fixed with 2% paraformaldehyde (PFA) before being placed in phosphate buffer containing 10 mM K3Fe(CN)6, 10 mM K4Fe(CN)6, and 1 mg/ml Xgal (Qiagen, Courtaboeuf, France, www.qiagen.com) at 37°C for 24 hours.

Immunocytochemistry

Cells were fixed with 4% PFA or methanol-acetone (50:50) and stained with antibodies against GATA-4 (goat polyclonal Ab [pAb], 1:20, R&D Systems, Minneapolis, MN, www.rndsystems.com, or rabbit pAb, 1:50, Santa Cruz Biotechnology, Santa Cruz, CA, www.scbt.com), β-galactosidase (chicken pAb, 1:500, Abcam, Cambridge, UK, www.abcam.com), Ki67 (rabbit pAb, 1:500, Abcam), Nkx2.5 (rabbit pAb, 1:50, Santa Cruz Biotechnology), myocyte enhancer factor 2C (MEF-2C; goat pAb, 1:50, Santa Cruz Biotechnology), desmin (rabbit pAb, 1:100, Abcam), cardiac troponin I (cTnI, rabbit pAb, 1:100; Abcam), α-sarcomeric actinin (mouse monoclonal Ab [mAb], 1:500, Sigma-Aldrich), α-smooth actin (rabbit pAb, 1:100, Abcam), prolyl four hydroxylase subunit beta (P4HB; mouse mAb, 1:100, Novus Biologicals, Littleton, CO, www.novusbio.com), GFP (rabbit pAb, 1:100, Gene Tex, Irvine, CA, www.genetex.com), Lamin A/C (rabbit pAb, 1:100, Cell Signaling Technology, Beverly MA, www.cellsignal.com), human Lamin A/C (mouse mAb, 1:100, Novocastra Laboratories, Newcastle, UK, www.novocastra.co.uk), or human mitochondria (mouse mAb, 1:800, Abcam). Donkey secondary anti-goat, anti-rabbit, anti-chicken, and anti-mouse antibodies (fluorescein isothiocyanate [FITC]–, Cy3-, or Cy5-conjugated, 1:100) were purchased from Jackson ImmunoResearch Laboratories (Suffolk, UK, www.jacksonimmuno.com). Nuclei were stained with Hoechst 33342 (Sigma-Aldrich). For costaining with phalloidin-rhodamine (5 μg/ml, Sigma-Aldrich) and FITC-conjugated α-tubulin (mouse mAb, 1:100, Abcam), hMADS cells were fixed with 4% PFA and then with cold acetone. For fluorescence analysis, we used a Zeiss (Le Pecq, France, www.zeiss.fr) Axioplan 2 Imaging microscope.

Real-Time Reverse Transcription Polymerase Chain Reaction

Total RNA was extracted from cells at coculture days 0, 1, 2, 4, and 7 by use of the Qiagen RNeasy Mini Kit (Qiagen), then reverse-transcribed with the Superscript First-Strand Synthesis System (Invitrogen) and Oligo(dT)20. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was performed in triplicate on a 7900 RT-PCR detection system (Applied Biosystems, Life Technologies, Carlsbad, CA, www.appliedbiosystems.com) with use of Platinium SYBR Green qPCR SuperMix (Invitrogen). PCR conditions were 50°C for 2 minutes, 95°C for 2 minutes, 45 cycles at 95°C for 15 seconds, and 60°C for 45 seconds, with glyceraldehyde 3-phosphate dehydrogenase used as the reference gene. Primer sequences are described in supporting information Table 1.

Results are reported as mean ± SD. Between-group comparisons for biochemical data involved the two-tailed Student's t test. p < .05 was considered statistically significant.

In Situ Hybridization

Fluorescence in situ hybridization (FISH) experiments were performed as described previously [38]. Cocultured cells were hybridized with human and mouse COT-1 DNA probes (Roche Diagnostics and Invitrogen) previously labeled by Nick translation (Roche Diagnostics) with Cy3 and biotin, respectively. Mouse biotin-labeled DNA was detected with a streptavidin-fluorescein conjugate (Sigma-Aldrich). In experiments combining GATA-4 immunocytochemistry and FISH, cocultured cells were stained with GATA-4 and then labeled with all human or all mouse centromere probes conjugated to FITC (Kreatech Diagnostics, Amsterdam, The Netherlands, www.kreatech.com). After hybridization, nuclei were counterstained with Hoechst and examined by confocal microscopy (Zeiss LSM 510 Meta).

Electronic Microscopy

Coculture-derived cells were fixed overnight in 3% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4, postfixed for 1.5 hours with 1% osmium tetraoxide, dehydrated by successive ethanol washes (50%, 70%, 80%, 95%, 100%, and 100%), and impregnated with epoxy resin. After polymerization, 70–80 nm sections were cut by use of a Reichert (Depew, NY, www.reichertspr.com) Ultracut E ultramicrotome, stained with 2% uranyl acetate plus Reynold's lead citrate, and visualized under a Philips CM120 transmission electron microscope.

Inhibition of F-Actin or Microtubule Polymerization

After proper cell adhesion (approximately 6 hours), cocultured cells were treated for 12 hours with 1 μM nocodazole to inhibit α-tubulin polymerization or 0.5 μM cytochalasin D or 0.25 μM latrunculin A, two inhibitors of f-actin polymerization. Inhibitory treatments were repeated 3 days later.

Stem Cell Mitochondria Transfer

Before coculturing, hMADS cells were labeled with MitoTracker Green FM (200 nM, Invitrogen). Images were obtained by time-lapse video microscopy (Leica [Wetzlar, Germany, www.leica-microsystems.com] DMI6000, Metamorph seven acquisition software, Universal Imaging) or fluorescence microscopy (Zeiss Axioplan 2 Imaging, Axiovision LE 4.6 software).

RESULTS

Fusion of hMADS Cells and Adult Cardiomyocytes Leads to Formation of Hybrid Cells with Cardiac Progenitor-Like Features

To investigate whether hMADS cells were fused with fully differentiated cardiomyocytes, we used a Cre/loxP system that allows lacZ gene expression only in fused cells. Cre-expressing hMADS cells were cocultured with cardiomyocytes from Rosa26R transgenic mice. From 2 days after coculture initiation, we detected colonies of small rounded cells that were lacZ-positive and whose morphology differed from that of both hMADS cells and adult cardiomyocytes (Fig. 1A). Xgal staining was not due to endogenous β-galactosidase activity because cocultures with nongenetically modified hMADS cells and Rosa26R mouse cardiomyocytes were devoid of blue cells (Fig. 1B). In addition, immunocytochemistry revealed that colony-derived cells coexpressed β-galactosidase with the early cardiac transcription factor GATA-4, which suggests that fused cells belonged to the cardiac lineage (Fig. 1C). Again, the presence of false-positive β-galactosidase cells in cocultures was ruled out by immunocytochemistry of cocultures without induction of the Cre/loxP system (Fig. 1D).

Figure 1.

Formation of GATA-4+ hybrid cells after fusion of human multipotent adipose-derived stem (hMADS) cells with cardiomyocytes. (A): Detection of hybrid cells (blue) by Xgal staining on day 2 of coculture of Rosa26R cardiomyocytes with Cre-hMADS cells (arrowhead). (B): Negative Xgal staining on coculture with nontransduced hMADS cells (arrowhead). (C, D): Coimmunostaining for β-galactosidase (β-Gal, white) and GATA-4 (red) on day 7 of coculture of Rosa26R cardiomyocytes and (C) Cre-hMADS cells or (D) nontransduced hMADS cells. Arrow, dead cardiomyocyte bodies. Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 50 μm (A–D).

To further characterize the phenotype of fused cells, we used immunostaining for GATA-4 with a series of markers directed against cardiac, smooth muscle or fibroblastic cells. GATA-4+ cells expressed early cardiac cell markers such as the transcription factors Nkx2.5 and MEF-2C (Fig. 2A, 2B). In contrast, later cardiac differentiation markers such as desmin and cardiac troponin I (cTnI) were expressed only in a small proportion (<5%) of GATA-4+ cells (Fig. 2C, 2D), and α-sarcomeric actinin was never detected (Fig. 2E). Furthermore, GATA-4+ colony-derived cells were negatively stained for α-smooth muscle actin and P4HB, which confirms that these cells did not originate from smooth muscle or fibroblastic lineages, respectively (Fig. 2F, 2G). Of note, hMADS cells that were cultured alone showed negative staining for all these antibodies, except P4HB. Finally, hybrid GATA-4+ cells expressed Ki67, a cell-cycling and proliferation marker (Fig. 2H and supporting information Fig. 1A). Counting of such hybrids from day 2 to 5 of coculture allowed for estimating their population doubling time at about 24 hours. MTT assay performed from day 8 to 14 of coculture depleted in human stem cells after 5 days of oubain exposure confirmed the proliferative potential of cardiac hybrid cells. Nevertheless, it also indicated that such potential was limited because cell growth decreased with time to become undetectable after 2 weeks of coculture (supporting information Fig. 1B, 1C).

Figure 2.

Phenotypic characterization of hybrid cells. Immunohistochemistry on day 7 of coculture showed that colony-derived GATA-4+ cells expressed (A) Nkx2.5 and (B) myocyte enhancer factor 2C but rarely (C) desmin and (D) cardiac troponin I and were negatively stained for (E) α-sarcomeric actinin, (F) α-smooth actin, and (G) prolyl 4 hydroxylase subunit beta (P4HB) fibroblastic markers. Human multipotent adipose-derived stem cells were positive for P4HB staining (arrow). (H): Day 7 coculture-derived GATA-4+ cells also expressed Ki67. (A–H): Antibodies were conjugated with FITC (green), except for GATA-4, which was conjugated with Cy3 (red). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 50 μm. Abbreviations: cTnI, cardiac troponin I; MEF-2C, myocyte enhancer factor 2C; P4HB, prolyl 4 hydroxylase subunit beta.

According to these results, cell fusion between stem cells and postmitotic cardiomyocytes led to the generation of hybrid cells exhibiting proliferative potential, the expression of early cardiac markers, and absence of an organized contractile cytoskeleton. These features were reminiscent of a cardiac progenitor cell type. Therefore, hybrid cells are hereafter designated cardiac progenitor-like cells.

Cardiac Progenitor-Like Cells Originate from Somatic Reprogramming of Cardiomyocytes, Not from Stem Cell Transdifferentiation

To determine the parental origin of cardiac genes expressed in hybrid cells, we performed qRT-PCR analysis with species-specific primers on cells cocultured from day 0–7. When compared with mouse cardiomyocytes alone, cocultured cells exhibited transcriptional activation of mouse genes involved in early cardiac commitment and proliferation, including GATA-4, MEF-2C, p300 (a histone acetyltransferase implicated in cardiac precursor cell induction [39]), and Ki67, whereas expression of later cardiac mouse genes such as desmin and cardiac troponin T (cTnT) appeared unaffected (Fig. 3A). In contrast, coculture cells and hMADS cells cultivated alone did not differ in human gene expression (Fig. 3B).

Figure 3.

Cell-fusion induction of somatic reprogramming of mouse cardiomyocytes. (A, B): Mouse and human gene expression changes during coculture assessed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) from day 0–7 of coculture. (C, D): Immunocytochemistry of mouse phenotype of colony GATA-4+ cells at day 7 of coculture. (C) A GATA-4+ (Cy3, red) colony expressing murine (Cy5, white) but not human (FITC, green) Lamin A/C. Arrow: human multipotent adipose-derived stem cells expressing human Lamin A/C but not GATA-4. (D): Coculture with GFP+ mouse cardiomyocytes leading to GATA-4+ (Cy3, red)/GFP+ (FITC, green) cells. (C, D): Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 50 μm. (E, F): qRT-PCR showing no modification of mouse- or human-cardiac gene expression when human and mouse cells were separated by permeable membrane. (G–J): qRT-PCR analysis of mouse and human gene expression on coculture with (G, H) human bone marrow-derived stem cells or (I, J) human MRC5 fibroblasts. (A, B, E–J): Data represent the mean ± SD of at least three independent experiments. *, p < .05; **, p < .01; ***, p < .001. Abbreviations: cTnT, cardiac troponin T; GFP, green fluorescent protein; h, human; h/m, human/mouse; hMADS cells, human multipotent adipose-derived stem cells; MEF-2C, myocyte enhancer factor 2C; MSC, mesenchymal stem cells.

qRT-PCR results suggesting a mouse phenotype of cardiac progenitor-like cells were further confirmed by immunostaining for GATA-4 with both human/mouse and human-specific Lamin A/C antibodies and by coculturing GFP+ transgenic mouse cardiomyocytes. As expected, progenitor-like GATA-4+ cells expressed only mouse Lamin A/C, as shown by the negative stain with human-specific antibody (Fig. 3C). In agreement with this finding, cardiac progenitor-like cells were GFP+, when coculture was performed with mouse GFP+ cardiomyocytes (Fig. 3D).

The mouse phenotype of hybrid cells highlighted that cellular fusion between stem cells and cardiomyocytes did not trigger cardiomyogenic conversion of stem cells but, rather, promoted somatic reprogramming of cardiomyocytes toward a progenitor-like state. To show that somatic reprogramming resulted from cell fusion, cocultures were performed with (i) a cell-culture insert to impede physical interactions between the two cell types without affecting the diffusion of soluble factors or (ii) living cardiomyocytes and hMADS cells previously killed with PFA to inhibit cellular fusion [40]. Indeed, PFA prefixation prevented fusion of live sperm cells or neural stem cells with fixed sea urchin eggs or endothelial cells, respectively, but did not disrupt receptor-mediated recognition and association of the cocultivated cell types [41, 42]. Reprogramming did not occur in either condition, which indicates that soluble signaling molecules or cell-to-cell interaction through a receptor had little or no effect on the generation of mouse cardiac progenitor-like cells (Fig. 3E, 3F and not shown).

Finally, we addressed the frequency of cardiomyocyte reprogramming by counting the number of immunostained cardiac βgal+/GATA-4+ hybrid cells resulting from cocultures rendered mitotically inactive by mitomycin C treatment. We detected a mean of 10 hybrid cells per 100,000 cardiomyocytes initially seeded. However, because propidium iodide staining and flow cytometry revealed that more than 90% of cardiomyocytes were suffering before coculture (supporting information Fig. 2), the rate of cardiomyocytes efficiently reprogrammed might be about 0.1% when considering the fraction of healthy cardiomyocytes at the start of coculture.

In addition, we tried to improve reprogramming efficiency by increasing cardiomyocyte survival in vitro because living cardiomyocytes were found to have limited lifespan (<24 hours) under our coculture conditions. We performed cocultures on laminin-coated dishes in the presence of medium containing insulin-transferrin-selenium and 2,3butanedione monoxime as reported previously [43]. Nevertheless, under these conditions, the yield of reprogrammed cardiomyocytes seemed not affected.

hBMS Cells but Not Human Fibroblasts Can Reprogram Mature Cardiomyocytes

To determine whether reprogramming of cardiomyocytes was specific to hMADS cells, we created cocultures with hBMS cells as another model of multipotent stem cells and with human fibroblasts (MRC5 cell line) as an example of proliferative cells devoid of plasticity potential. qRT-PCR of hBMS cell cocultures revealed results similar to those with hMADS cells: increased transcription of mouse but not human genes involved in proliferation and early cardiac commitment such as Ki67, GATA-4, MEF-2C, and p300, as well as unchanged expression of both mouse and human later cardiac differentiation genes such as desmin and cardiac troponin T (Fig. 3G, 3H). In contrast, coculture with MRC5 fibroblasts resulted in different mouse and human gene expression patterns. Even fibroblasts promoted enhanced transcription of mouse GATA-4; they failed to enhance that of mouse p300 and MEF-2C, which indicates that reprogramming of mouse cardiomyocytes was incomplete (Fig. 3I). On the other hand, coculture with human fibroblasts exhibited increased transcription of human GATA-4 gene, which suggests that these cells initiate a process of cardiomyogenic conversion (Fig. 3J). Accordingly, somatic reprogramming seems to be a feature of multipotent stem cells that is not shared by fibroblastic cells.

Cardiomyocyte Reprogramming Is Mainly Mediated by a Partial Cell-Fusion Process

To gain additional insights into the mechanisms underlying somatic reprogramming, we investigated whether hybrid cells originated from permanent or partial cell fusion processes. The occurrence of permanent cell fusion was tested by FISH nuclear staining with species-specific DNA probes. Rare synkaryons (1:200 hybrid cells) whose nuclei exhibited both human and mouse DNA were detected by this method (Fig. 4A), whereas colony-derived GATA-4+ cells contained only mouse DNA (Fig. 4B–4D). Such observations argued against permanent cell fusion as the principle mechanism of the formation of cardiac progenitor-like hybrid cells. Further supporting this hypothesis, live cell imaging and electron microscopy revealed partial cell fusion events between cocultured hMADS cells and cardiomyocytes. Live cell imaging microscopy revealed intercellular structures resembling tunneling nanotubes that ensure membrane continuity between stem cells and cardiac cells (Fig. 5A, 5B). Electron microscopy revealed two other types of heterocellular interactions: one connecting distant cells and consisting in long slender protrusions differing from nanotubes in that they adhered to the substratum [44] (Fig. 5C, 5D) and the other consisting in focal, broad, tight cell-to-cell contact between neighboring cells (Fig. 5F). Membrane disruptions suggestive of partial cell fusion seemed to occur focally in both cases (Fig. 5E, 5G). Cytoskeletal composition of intercellular structures connecting hMADS cells and cardiomyocytes was then analyzed by staining f-actin and microtubules with phalloidin and anti-α-tubulin antibody, respectively; most of the intercellular communications between the two cultivated cell types contained both microtubule and f-actin filaments (Fig. 6A, 6B).

Figure 4.

Analysis of nuclear fusion events during coculture. (A, B): Fluorescence in situ hybridization (FISH) with mouse (fluorescein isothiocyanate [FITC]) and human (Cy3) COT-1 DNA probes. (A): Right panel: detection of synkaryons containing human (red) and mouse (green) DNA (arrows) 2 days after coculture initiation. Arrowhead: human multipotent adipose-derived stem (hMADS) cells labeled with only human COT-1 probe. Left and middle panels: double FISH performed on mouse cardiomyocytes or hMADS cells alone, respectively. Star: cardiomyocyte body aggregate. (B): Nuclei of colony cells expressing mouse but not human COT-1 DNA. Arrow: human nucleus (red). (C, D): Immunocytochemistry on day 2 of coculture with GATA-4 combined with FISH labeling with FITC-conjugated human or mouse all centromere probes (green) confirmed that GATA-4+ nuclei (Cy3, red) contained (C) mouse but (D) not human DNA. Human nuclei devoid of GATA-4 staining are also shown. (A–D) Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 20 μm.

Figure 5.

Occurrence of partial cell fusion events during coculture. (A, B): Live cell imaging at 6 hours after coculture initiation revealed thin membranous channels (arrowheads) connecting human multipotent adipose-derived stem (hMADS) cells (arrow) to cardiomyocytes (stars). Scale bar: 20 μm. (C–G): Electron microscopy images illustrating various types of intercellular interactions between hMADS cells and mouse cardiomyocytes in 24-hour cocultures. (C–E): Adherent long slender protrusions connecting hMADS cells to distant cardiomyocytes. (C): Partial view of a long hMADS cell protrusion surrounding a cardiomyocyte membrane (arrowheads). Scale bar: 378 nm. (D): Terminal portion of a protrusion. Scale bar: 644 nm. (E): Higher magnification of the contact area shown in (D) with blurring (arrowhead) and suspected focal loss (arrow) of the two plasma membranes. Scale bar: 275 nm. (F): Close membrane apposition between stem cells and cardiac cells. Scale bar: 863 nm. (G): Higher magnification of the contact site shown in (F) suggesting membrane disruption (arrows). Scale bar: 410 nm. Abbreviations: CM, cardiomyocytes.

Figure 6.

Involvement of f-actin and microtubule filaments in cardiomyocyte reprogramming. (A): Six hours after coculture initiation, thin membrane channels interconnecting stem (arrow) to cardiac (arrowhead) cells contained both f-actin (rhodamine-phalloidin staining, red) and microtubules (fluorescein isothiocyanate–conjugated α-tubulin, green). (B): Close membrane apposition between stem cells and cardiac cells showing concentration of microtubule (green) and f-actin (red) filaments at the contact site. Scale bar: 10 μm (A, B). (C, D): Impaired somatic reprogramming by inhibitors of f-actin (cytochalasin D 0.5 μM, latrunculin A 0.25 μM) or microtubule polymerization (nocodazole 1 μM) assessed by real-time reverse transcription polymerase chain reaction at 7 days of coculture. No statistical differences between inhibitory effects of nocodazole, cytochalasin D, or latrunculin A were observed. Relative expression was compared with day 7 untreated cocultures. Data represent the mean ± SD of at least three independent experiments *, p < .05; **, p < .01; ***, p < .001. Abbreviations: cTnT, cardiac troponin T; MEF-2C, myocyte enhancer factor 2C.

To assess the involvement of such connections in somatic reprogramming, cocultured cells were transiently treated to not alter cell viability with cytochalasin D or latrunculin A, two inhibitors of f-actin polymerization, or with nocodazole, which inhibits α-tubulin polymerization. The expression of mouse and human cardiac genes was analyzed in day 7 cocultures by qRT-PCR. When compared with untreated cocultures, nocodazole-, cytochalasin D-, or latrucunlin A-treated cocultures showed decreased transcriptional expression of mouse early cardiac GATA-4 gene with relative abundances of 0.7, 0.6, and 0.82, respectively. This effect was associated with increased expression of mouse later cardiac genes, with relative abundances of 3, 3.8, and 2 for desmin and 2.7, 3.1, and 2.8 for cardiac troponin T, respectively (Fig. 6C). This cardiac gene expression pattern being reminiscent of that of fully differentiated cardiomyocytes, these results indicated that transient disruption of f-actin filaments or microtubules prevented cardiomyocyte reprogramming back to a progenitor-like state. In addition, we observed an increased level of transcripts encoding for human GATA-4 and desmin, whereas the expression of human MEF-2C remained quite similar to that in untreated cocultures (Fig. 6D). These data indicated that transient disruption of f-actin or microtubule networks favored transdifferentiation of hMADS cells into a cardiac lineage. The phenotype of transdifferentiated hMADS cells was further characterized by immunohistochemistry. We detected the protein expression of GATA-4 but not desmin, cardiac troponin I, or MEF-2C, which supports that cardiomyogenic conversion of hMADS cells was incomplete (supporting information Fig. 3 and data not shown). Interestingly, the effect of nocodazole on mouse and human cardiac gene transcription was comparable with that of cytochalasin D and latrunculin A (no significant statistical differences between drugs) (Fig. 6C, 6D). Thus, f-actin and microtubules may act in concert and hence, somatic reprogramming might be mainly mediated by intercellular structures containing both f-actin and α-tubulin filaments.

Transfer of Functional Stem Cell Mitochondria into Cardiomyocytes Is Essential for Somatic Reprogramming

Because the transfer of functional mitochondria from stem cells was suggested to rescue cardiomyocytes in coculture [21], we analyzed whether mitochondria of hMADS cells labeled with mitotracker before coculture were transferred to mouse cardiomyocytes. As soon as 6 hours after coculture initiation, live cell imaging revealed some mouse cardiomyocytes containing fluorescent human mitochondria (Fig. 7A). Passive transfer of human mitochondria toward cardiomyocytes was tested in indirect cocultures in which hMADS cells previously labeled with mitotracker dye were separated from cardiomyocytes by an 8-μm–pore cell-culture insert. Under these conditions, cardiomyocytes were unable to capture mitotracker dye from hMADS cells, which supports that stem cell mitochondria were mainly transferred through intercellular structures and not from extracellular medium (data not shown). Accordingly, human mitochondria were detected inside intercellular structures connecting hMADS cells to cardiomyocytes (Fig. 7B).

Figure 7.

Role of functional stem cell mitochondria transfer toward cardiomyocytes for somatic reprogramming. (A): Microscopy live-cell imaging in a 6-hour coculture showing human multipotent adipose-derived stem (hMADS) cell mitochondria (MitoTracker Green FM) in cardiomyocyte (arrowhead). Arrow points to an hMADS cell. (B): Presence of human mitochondria (MitoTracker Green FM) inside a tunneling nanotube-like structure connecting a stem cell to a cardiac cell and into cardiomyocyte cytoplasm (arrowhead; 12-hour coculture, PFA-fixed cells). (C): Despite their mouse phenotype, β-gal+ (Cy5, white)/GATA-4+ (Cy3, red) hybrid cells show human stem cell mitochondria in their cytoplasm (fluorescein isothiocyanate, green). (D): Human mitochondria antibody used in (C) stained human but not mouse cells (left and right panels, respectively). (E) MitoTracker green staining showing mitochondrial DNA depletion in hMADSρ0 cells (ethidium bromide-treated, right panel) when compared with untreated hMADS cells (left panel). (F) Day 7 coculture of Cre-hMADSρ0 cells and Rosa26R mouse cardiomyocytes shows a marked decrease in number of β-gal+/GATA-4+ hybrid cells (Cy5, white, and Cy3 red staining, respectively) when compared with (G) untreated cocultures. Scale bar: 20 μm (A–E), 50 μm (F, G). (H): Real-time polymerase chain reaction assays showing human (right panel) and mouse (left panel) cardiac gene expression on coculture with hMADSρ0 cells when compared with untreated cocultures. Data represent the mean ± SD of at least three independent experiments. **, p < .01; ***, p < .001. Abbreviations: cTnT, cardiac troponin T; DIC, differential interference contrast microscopy; MEF-2C, myocyte enhancer factor 2C.

To determine whether transferred human mitochondria persisted in mouse progenitor-like cells derived from cell fusion, day 7 cocultures of Rosa26R mouse cardiomyocytes and hMADS cells expressing Cre recombinase underwent immunocytochemistry for GATA-4, β-gal, and human mitochondria. Human mitochondria were revealed inside the cytoplasm of mouse-reprogrammed GATA-4+/β-gal+ cells (Fig. 7C). As expected, the human mitochondria antibody stained human but not mouse cells (Fig. 7D).

To assess the role of stem cell mitochondria transfer in cardiomyocyte reprogramming, hMADS cells were pretreated for a long time (>1 month) with low doses of ethidium bromide. Such a treatment allows mutations and depletion of mitochondrial DNA without altering nuclear function, as reported previously for other cell types [32–34]. After 1 month of ethidium bromide exposure, more than 95% of treated cells, commonly designated as hMADSρ0 cells, exhibited greatly decreased mitochondrial DNA when compared with untreated hMADS cells (Fig. 7E). To investigate their cell fusion ability, hMADSρ0 cells were genetically modified to express Cre recombinase before coculture with Rosa26R mouse cardiomyocytes. The proportion of cardiac GATA-4+/β-gal+ progenitor-like cells was 70–90% lower in treated (Fig. 7F) than untreated cocultures (Fig. 7G), indicating that functional stem cell mitochondria transfer is essential for successful achievement of somatic reprogramming. The detection of a low amount of fused cardiac progenitor-like cells was likely due to the presence in the hMADSρ0 cell population of a few human cells whose mitochondria were still unaltered. The requirement of functional stem cell mitochondria for reprogramming was confirmed by qRT-PCR analysis. When compared with untreated cocultures, hMADSρ0 cell cocultures showed significantly decreased mouse early but also late cardiac differentiation transcripts, with relative abundances of 0.43 for GATA-4, 0.22 for MEF-2C, 0.02 for desmin, and 0.07 for cTnT (Fig. 7H, left panel). The relative transcription level of mouse GATA-4 and MEF-2C genes should reflect the presence of a few cardiac hybrid cells previously identified by immunocytochemistry, whereas the marked decrease of mouse desmin and cTnT transcripts strongly suggests that in the absence of functional stem cell mitochondria, adult cardiomyocytes died, which explains why they were unable to be reprogrammed. Again, concomitant with somatic reprogramming inhibition, we observed enhanced transcription of human GATA-4 gene, with a relative abundance of 2.71 when compared with that in untreated cocultures, which suggests the entry of hMADS cells into the cardiomyogenic lineage (Fig. 7H, right panel).

DISCUSSION

To further characterize stem cell fusion as tissue repair mechanism, our study provides the first evidence that hMADS cells can rescue postmitotic cardiomyocytes in vitro via cell fusion and reprogramming to a rejuvenated progenitor-like state. Interestingly, hBMS cells but not human fibroblasts exhibited similar reprogramming ability, which suggests that this feature is restricted to some types of multipotent stem cells. Another important consideration concerns the frequency with which somatic reprogramming occurs. According to our results, the rate of this phenomenon is rare and might be underestimated because of the poor viability of cardiomyocytes after dissociation from the heart and their low survival potential on culture. Consequently, future efforts to optimize reprogramming efficiency might focus on improving methods for dissociation from the heart and culture of mouse cardiomyocytes.

Additionally, our study reveals information on the phenotype of hybrid cardiac cells, which was until now largely unexplored. We found that fused cells are in fact an intermediate state between stem cells and fully differentiated cells because they look like a type of cardiac progenitor in terms of their proliferative potential, expression of early cardiac transcription factors and lack of contractile proteins. Therefore, whether such cells resemble or differ from cardiac progenitors or cardiac stem cells reported to reside in heart tissue [15, 45–47] remains a question that requires further knowledge of cardiac hybrid cells. In particular, whether coculture-derived hybrid cells can differentiate into beating cardiomyocytes needs to be determined to show whether they are truly cardiac progenitors. Although this phenomenon was never observed in our coculture conditions, we cannot exclude that such a differentiation could occur in experimental settings more faithfully reproducing the heart environment. In strengthening this hypothesis, recent unpublished data from our lab suggest that cardiac hybrid cells generated by coculture differentiate into mature cardiomyocytes in vivo when engrafted into mouse infarcted myocardium.

Besides assessing the hybrid phenotype, our study also provides insights into mechanisms underlying cell fusion processes leading to cardiomyocyte reprogramming. Despite the occurrence of permanent cell fusion during coculture, this process fails to fully explain the generation of hybrid cells in terms of its frequency, which is extremely rare, and the fact that we never detected colonies of synkaryons expressing GATA-4. Rather, our observations favor a role of partial cell fusion in the emergence of cardiac hybrid cells. Evidence of partial cell fusion events in vitro was reported from coculture of neonatal cardiomyocytes and endothelial progenitor cells or bone marrow-derived stem cells [21, 48]. These studies revealed thin membranous connections between stem cells and cardiac cells, but did not consider their cytoskeletal composition. Here, we report the possibility of partial cell fusion by transient thin channels resembling tunneling nanotubes or by close cell-to-cell membrane apposition accompanied by focal membrane disruption. Our results also highlight the involvement of both f-actin and microtubule filaments in this process. These two cytoskeletal components may act in concert inside the same intercellular connections. Interestingly, intercellular channels containing both f-actin and microtubules have been described to transfer mitochondria between macrophages in vitro [29] and, according to our observations, may also participate in conveyance of stem cell mitochondria toward cardiomyocytes.

Despite previous evidence of cell-to-cell connections and organelle transfer between stem cells and cardiac cells [20, 21], the formation of cardiac progenitor-like cells has never been reported in coculture studies. The fact is probably ascribable to differences in developmental stage of cardiomyocytes used for coculture. Indeed, other investigators used neonatal cardiac cells capable of division [7, 49, 50], whereas we used nonreplicative adult cardiomyocytes.

Finally, one of the most exciting outcomes of our study relates to the role of stem cell mitochondria in cardiomyocyte reprogramming. Here, we provide the first evidence to our knowledge that human stem cell mitochondria transferred toward mature cardiomyocytes persisted over time in mouse cardiac progenitor-like cells derived from cell fusion. Importantly, we found that depletion of stem cell mitochondrial DNA did not alter the cell fusion ability of stem cells but, rather, led to a dramatic decrease in somatic reprogramming frequency. Thus, delivery of stem cell intact mitochondria to distressed cardiomyocytes whose mitochondria are rapidly altered after isolation may prolong the survival of such cells and maintain their nuclear integrity, which is a prerequisite for reprogramming.

In support of our findings, Spees et al. [34] recently described that transfer of stem cell mitochondria can rescue aerobic respiration in mammalian cells with nonfunctional mitochondria. However, whether stem cell mitochondria may affect somatic reprogramming by favoring cardiomyocyte transcriptional machinery remodeling through conveyance of key factors from stem cells or by modulating transcription factor activities into cardiomyocytes through mitochondria-to-nucleus retrograde signaling is yet unclear [51]. Whatever the fine mechanisms by which stem cell mitochondria sustain somatic reprogramming, these findings may reconcile current controversies about mechanisms underlying the cardiac benefit of stem cells by proposing an alternative regenerative pathway to other well-accepted candidates including transdifferentiation, permanent cell fusion, and paracrine effects. In particular, transfer of stem cell mitochondria may well explain why heart functional improvements are observed despite the fact that few of the donor cells are engrafted at long-term. Nevertheless, determining whether partial cell fusion, mitochondria transfer, and cardiomyocyte reprogramming take place in vivo is currently difficult. However, several recent studies have strengthened the hypothesis that such processes occur in living tissues. For instance, the existence of tunneling nanotubes has been confirmed in cornea following injury [52], and heart regeneration in zebrafish has been shown to be mediated by cardiomyocyte dedifferentiation and proliferation [53].

Future research into partial cell fusion will contribute to a better understanding of the regenerative properties of stem cells and lead to the development of more efficient cell therapies to treat heart degenerative diseases.

CONCLUSION

Our study provides the first evidence that adult stem cells can reprogram cardiomyocytes back to a more immature state through partial cell fusion processes and transfer of functional mitochondria. The timeline of cardiomyocyte reprogramming is summarized in supporting information Figure 4. In contrast, permanent cell fusion and the formation of synkaryons were rare in our coculture conditions and therefore do not seem to be the principle mechanisms of hybrid cardiac cell generation.

Acknowledgements

We are grateful to M. Goossens, A. d'Anglemont de Tassigny, T Piolot, and X Decrouy for their helpful advice regarding FISH, cardiomyocyte dissociation, time-lapse videomicroscopy, and confocal microscopy experiments, respectively. This work was supported by INSERM, the Association Française contre les Myopathies, and the Association pour la Recherche et l'Etude des Maladies Cardiovasculaires.

DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST

The authors indicate no potential conflicts of interests.

Ancillary